Rachel Sachs

Associate Professor of Law

Rachel Sachs

View all WashU Experts


Rachel Sachs is a scholar of innovation policy whose work explores the interaction of intellectual property law, food and drug regulation, and health law. Her work examines problems of innovation and access, considering how law helps or hinders these problems.

WashU in the News


Rachel Sachs

Be very, very concerned about what Allergan just did

Yesterday, it was announced that Allergan had transferred the ownership of the patents on its billion-dollar drug Restasis, used for the treatment of chronic dry eye, to the Saint Regis Mohawk Tribe. The Tribe then exclusively licensed the drug back to Allergan, in exchange for tens of millions of dollars in both licensing and royalty fees. Although it may not sound like it, this transfer is potentially huge news in the drug pricing world. It is also extremely complex, and its full implications have yet to be determined.